Successful liver transplantation across the ABO incompatibility barrier in 6 cases of biliary atresia

Journal of Pediatric Surgery

Volumn 41, Issue 12, 2006, Pages 1976-1979

  Yamada, Yohei ^a   Hoshino, Ken ^a   Morikawa, Yasuhide ^a   Okamura, Jun ^a   Hotta, Ryo ^a   Komori, Koji ^a   Nakao, Shioko ^a   Obara, Hideaki ^a   Kawachi, Shigeyuki ^a   Fuchimoto, Yasushi ^a   Tanabe, Minoru ^a   Shimazu, Motohide ^a   Kitajima, Masaki ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

ABO incompatible liver transplantation; Children; Humoral rejection; Intraportal infusion therapy

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GABEXATE MESILATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PROSTAGLANDIN E1; RITUXIMAB; STEROID; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BILE DUCT ATRESIA; BLOOD COMPATIBILITY; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG SUBSTITUTION; EPSTEIN BARR VIRUS; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; PERIOPERATIVE PERIOD; PLASMAPHERESIS; PORTAL VEIN; PRIORITY JOURNAL; SPLENECTOMY; TREATMENT OUTCOME; VIRUS INFECTION;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; ALPROSTADIL; BILIARY ATRESIA; CHILD; CLINICAL PROTOCOLS; GABEXATE; GLUCOCORTICOIDS; GRAFT REJECTION; GRAFT SURVIVAL; HEMATOLOGIC AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFUSIONS, INTRAVENOUS; LIVER TRANSPLANTATION; PLASMA EXCHANGE; PORTAL VEIN; SPLENECTOMY; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33845229330     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2006.08.021     Document Type: Article

References (14)

1. Farges O., Nocci Kalil A., Samuel D., et al. Long-term results of ABO-incompatible liver transplantation. Transplant Proc 27 2 (1995) 1701-1702
2. Gugenheim J., Samuel D., Reynes M., et al. Liver transplantation across ABO blood group barrier. Lancet 336 8714 (1990) 519-523
3. Mor E., Skerrett D., Manzarbeitia C., et al. Successful use of an enhanced immunosuppressive protocol with plasmapheresis for ABO-incompatible mismatched grafts in liver transplant recipients. Transplantation 59 7 (1995) 986-990
4. Yandza T., Lambert T., Alvarez F., et al. Outcome of ABO-incompatible liver transplantation in children with no specific alloantibodies at the time of transplantation. Transplantation 58 1 (1994) 46-50
5. Cacciarelli T.V., So S.K., Lim J., et al. A reassessment of ABO incompatibility in pediatric liver transplantation. Transplantation 60 7 (1995) 757-760
6. Egawa H., Oike F., Buhler L., et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 77 3 (2004) 403-411
7. Demetris A.J., Jaffe R., Tzakis A., et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 132 3 (1988) 489-502
8. Haga H., Egawa H., Shirase T., et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABO-incompatible liver transplantation. Liver Transpl 10 1 (2004) 16-27
9. Takahashi K., Yagisawa T., Sonoda K., et al. ABO-incompatible kidney transplantation in a single-center trial. Transplant Proc 25 1 Pt 1 (1993) 271-273
10. American Academy of Pediatrics, Committee on infectious Diseases. Recommendations for prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 106 (2000) 362-366
11. Yoshizawa A., Sakamoto S., Ogawa K., et al. New protocol of immunosuppression for liver transplantation across ABO barrier: the use of rituximab, hepatic arterial infusion, and preservation of spleen. Transplant Proc 37 4 (2005) 1718-1719
12. Allison A.C., and Eugui E.M. Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil. Immunol Rev 136 (1993) 5-28
13. Hanto D.W., Fecteau A.H., Alonso M.H., et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl 9 1 (2003) 22-30
14. Tanabe M., Shimazu M., Wakabayashi G., et al. Intraportal infusion therapy as a novel approach to adult ABO-incompatible liver transplantation. Transplantation 73 12 (2002) 1959-1961